Regenerative Medicine
HIV/AIDS
News Release - November 4, 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Source: BioTime
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.